Frankfurt: Novartis breast most cancers drug Kisqali minimize the risk of recurrence by a bit of greater than 25 per cent in a pivotal trial on girls recognized at ...
India ought to have a regulatory data protection system in place to attract basic drug analysis from main pharmaceutical corporations on the planet, Novartis Chief Executive Officer Vasant Narasimhan ...